Last Update Time: 19-Mar-2025 16:00:00
ISIN: INE685A01028
Sector: Healthcare
Symbol: TORNTPHARM

Torrent Pharmaceuticals Limited

₹3,183.55 ₹47.85 (1.53%) ▲
Prev. Close ₹3,135.70
Open ₹3,135.70
Close ₹3,191.30
Range ₹3,024.37 - ₹3,342.73
High ₹3,200.00
Low ₹3,075.00
Ind. Close ₹0.00
VWAP ₹3,167.00

The current stock price of Torrent Pharmaceuticals Limited is ₹3,183.55, with a target price range between ₹3,024.37 and ₹3,342.73. The stock has experienced a price change of ₹47.85 (1.53%), reflecting recent market volatility.

Today's opening price was ₹3,135.70, while the previous close stood at ₹3,135.70.

The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.

For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.

Torrent Pharmaceuticals Limited Price Chart

Torrent Pharmaceuticals Limited Pre Open Market Overview: 19-Mar-2025

Key Metrics:

  • IEP (Indicative Equilibrium Price): 3135.7
  • Previous Close Price: 3135.7
  • Change: 0.00%
  • Total Traded Volume: 205
  • Total Buy Quantity: 625
  • Total Sell Quantity: 1,250
Price Buy Qty Sell Qty
3,113.50 1.00 0.00
3,115.00 3.00 0.00
3,120.00 35.00 0.00
3,121.70 50.00 0.00
3,129.70 10.00 0.00
3,135.70 0.00 464.00
3,141.90 0.00 1.00
3,144.00 0.00 20.00
3,144.90 0.00 4.00
3,148.00 0.00 20.00

ATO Data:

  • Buy Quantity (ATO): 0
  • Sell Quantity (ATO): 0

Order Book

Bid Qty Ask Qty
0.00 0 0.00 0
0.00 0 0.00 0
0.00 0 0.00 0
0.00 0 0.00 0
0.00 0 0.00 0
Total Buy Quantity: 625 Total Sell Quantity: 1250

Shareholding Patterns of Torrent Pharmaceuticals Limited

Key Trade Statistics of Torrent Pharmaceuticals Limited

Trade Information Details
Traded Volume (Lakhs) 3.58
Traded Value (₹ Cr.) 113.45
Total Market Cap (₹ Cr.) 107,745.80
Free Float Market Cap (₹ Cr.) 29,852.81
Impact cost 0.03
Quantity Traded 358,238.00
Deliverable Quantity 232,624.00
% of Quantity to Traded 64.94
Security VaR 9.26
Index VaR N/A
VaR Margin 9.26
Extreme Loss Rate 3.5
Adhoc Margin N/A
Applicable Margin Rate 12.76
Face Value 5

Key Price Statistics of Torrent Pharmaceuticals Limited

The 52-week high for Torrent Pharmaceuticals Limited was ₹3,590.70, recorded on 09-Oct-2024. On the other hand, the 52-week low stands at ₹2,487.80, with the lowest value recorded on 19-Mar-2024.

The upper band for trading is ₹3,449.25, and the lower band is ₹2,822.15. The price band is No Band%.

The stock's daily volatility stands at 1.48, while the annualized volatility is 28.28. The tick size for trading is ₹0.05.

Price Information Details
52 Week High (09-Oct-2024) 3,590.70
52 Week Low (19-Mar-2024) 2,487.80
Upper Band 3,449.25
Lower Band 2,822.15
Price Band (%) No Band
Daily Volatility 1.48
Annualised Volatility 28.28
Tick Size 0.05

Key Securities Statistics of Torrent Pharmaceuticals Limited

Securities Information Details
Status Listed
Trading Status Active
Date of Listing 25-Nov-2002
Adjusted P/E 57
Symbol P/E 57
Index NIFTY NEXT 50
Macro-Economic Sector Healthcare
Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Basic Industry Pharmaceuticals

Security Status of Torrent Pharmaceuticals Limited

Title Details
Board Status Main
Trading Segment Normal Market
Session No. -
Class of Shares Equity
SDD Compliance -
Name of Compliance Officer -

Announcements of Torrent Pharmaceuticals Limited

Subject Date
Credit Rating 19-Mar-2025
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent 27-Feb-2025
Resignation 27-Feb-2025
Analysts/Institutional Investor Meet/Con. Call Updates 21-Feb-2025
Action(s) initiated or orders passed 17-Feb-2025
Analysts/Institutional Investor Meet/Con. Call Updates 14-Feb-2025
Analysts/Institutional Investor Meet/Con. Call Updates 08-Feb-2025
Analysts/Institutional Investor Meet/Con. Call Updates 07-Feb-2025

Corporate Actions of Torrent Pharmaceuticals Limited

Face Value Purpose Ex-Date Start Date End Date
5 Interim Dividend - Rs 26 Per Sh 31-Jan-2025 - -
5 Dividend - Rs 6 Per Share 21-Jun-2024 - -
5 Interim Dividend - Rs 22 Per Share 12-Feb-2024 - -
5 Dividend - Rs 8 Per Share 23-Jun-2023 - -
5 Interim Dividend - Rs 14 Per Share 03-Feb-2023 - -
5 Bonus 1:1 08-Jul-2022 - -
5 Interim Dividend - Rs 25 Per Share 02-Feb-2022 - -
5 Dividend - Rs 15 Per Share 17-Jun-2021 - -
5 Interim Dividend - Rs 20 Per Share 15-Feb-2021 - -
5 Interim Dividend - Rs 17 Per Share Special Dividend - Rs 15 Per Share 18-Mar-2020 - -
5 Dividend Rs 4 Per Share 13-Jun-2019 - -
5 Interim Dividend - Rs 13 Per Share 06-Feb-2019 - -
5 Dividend- Rs 5 Per Share 18-Jun-2018 20-Jun-2018 22-Jun-2018
5 Interim Dividend Rs 9/- Per Share (Purpose Revised) 15-Feb-2018 - -
5 Dividend - Rs 4/- Per Share 19-Jun-2017 21-Jun-2017 23-Jun-2017
5 Interim Dividend Rs 10/- Per Share (Purpose Revised) 10-Feb-2017 - -
5 Interim Dividend - Rs 15/- Per Share (Purpose Revised) 16-Mar-2016 - -
5 Interim Dividend - Rs 20/- Per Share (Purpose Revised) 11-Feb-2016 - -
5 Dividend - Rs 6.25/- Per Share 15-Jun-2015 17-Jun-2015 19-Jun-2015
5 Interim Dividend - Rs 5/- Per Share (Purpose Revised) 02-Feb-2015 - -

Board Meetings of Torrent Pharmaceuticals Limited

Purpose Details Att. Mtg. Date
Board Meeting Intimation Torrent Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 24-Jan-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Dividend/Other business. 24-Jan-2025
Financial Results/Dividend/Other business matters To consider and approve the financial results for the period ended December 31, 2024, dividend and other business matters 24-Jan-2025
TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 25-Oct-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2024 and Other business. Board Meeting Intimation 25-Oct-2024
Financial Results/Other business matters To consider and approve the financial results for the period ended September 30, 2024 and other business matters 25-Oct-2024
TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-Jul-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Other business. Board Meeting Intimation 23-Jul-2024
Financial Results/Other business matters To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters 23-Jul-2024
TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 24-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend/Fund raising/Other business. Board Meeting Intimation 24-May-2024
Financial Results/Dividend/Fund Raising To consider and approve the financial results for the period ended March 31, 2024, dividend and Fund Raising 24-May-2024
TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Dividend/Other business. Board Meeting Intimation 02-Feb-2024
Financial Results/Dividend/Other business matters To consider and approve the financial results for the period ended December 31, 2023, dividend and other business matters 02-Feb-2024
TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2023 and Other business. Board Meeting Intimation 23-Oct-2023
Financial Results To consider and approve the financial results for the period ended September 30, 2023 We would like to inform you that a meeting of the Board of Directors will be held on Monday, 23-Oct-23, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-23. 23-Oct-2023
TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 . Board Meeting Intimation 07-Aug-2023
TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend/Fund raising/Other business. Board Meeting Intimation 30-May-2023
Financial Results/Dividend/Other business matters To consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters 30-May-2023
Financial Results/Dividend/Other business matters To consider and approve the financial results for the period ended December 31, 2022, dividend and other business matters 25-Jan-2023
Financial results/Other business matters Torrent Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 21-Oct-2022 to consider financial statements for the period ended September 2022 and Other business matters 21-Oct-2022
Financial results/Other business matters Torrent Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 29-Jul-2022 to consider financial statements for the period ended June 2022 29-Jul-2022
Bonus Torrent Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 25-May-2022 to consider Bonus 25-May-2022
Dividend/Financial results/Fund raising Torrent Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 25-May-2022 to consider financial statements for the period ended March 2022, Dividend and Fund raising 25-May-2022

Financial Results of Torrent Pharmaceuticals Limited

Company Directory of Torrent Pharmaceuticals Limited

Web Address SM Name Office Address City Pincode Telephone Email
www.torrentpharma.com Torrent Pharmaceuticals Limited Registered Office Torrent House,
Off. Ashram Road,
Navarangpura
AHMEDABAD 380009 079-07926599000 investorservices@torrentpharma.com
www.torrentpharma.com Torrent Pharmaceuticals Limited Transfer Agent KFin Technologies Limited
Selenium Tower, Tower B, Plot No. 31 & 32,
Financial District, Gachibowli, Nanakramguda,
Hyederabad
HYDERABAD 500032 040-67162222 einward.ris@kfintech.com

Insider Trading of Torrent Pharmaceuticals Limited

Reg. Clause Acq./Disp. Sec. (No.) Sec. Value Txn Type Bcast Time
7(2) Jinesh Shah, Designated Person (in capacity of trustee of Jinesh Trust) 930144 0 Buy 29-Nov-2024 18:16
7(2) Shailesh Haribhakti 3600 10058040 Pledge 20-Oct-2021 12:32
7(2) Shailesh Haribhakti 6875 19936893 Buy 25-Jun-2021 19:56
7(2) Shailesh Haribhakti 1050 2944025 Buy 03-Jun-2021 19:45
7(2) Shailesh Haribhakti 1820 5005018 Buy 02-Jun-2021 12:11
7(2) Shailesh Haribhakti 730 1997986 Buy 01-Jun-2021 18:13
7(3) Harish Guttikar 400 1086400 Buy 07-Jan-2021 13:29
7(3) Harish Guttikar 200 555600 Sell 07-Jan-2021 13:29
7(2) Karan Shah 117 257562 Buy 03-Oct-2020 20:10
7(2) Karan Shah 1085 2329360 Buy 03-Oct-2020 20:10
7(2) Karan Shah 117 257700 Sell 03-Oct-2020 20:10
7(2) Karan Shah 1085 2313319 Sell 03-Oct-2020 20:10
7(2) Ameera Shah 1200 2664000 Sell 27-Feb-2020 19:03
7(2) Ameera Shah 1200 1993738 Buy 15-Nov-2018 19:26
7(2) Shailesh Haribhakti 6000 8391600 Sell 29-Dec-2017 18:23
7(2) Torrent Private Limited 25589384 35850726984 Buy 30-Mar-2017 20:40
7(2) Anita Sudhir Mehta 6120168 8574355368 Sell 30-Mar-2017 20:40
7(2) Sudhir Uttamlal Mehta HUF 1717380 2406049380 Sell 30-Mar-2017 20:40
7(2) Sudhir Uttamlal Mehta 5885276 8245271676 Sell 30-Mar-2017 20:40
7(2) Samir Uttamlal Mehta HUF 2079900 2913939900 Sell 30-Mar-2017 20:40

Annual Reports of Torrent Pharmaceuticals Limited

Company From Year To Year Att.
Torrent Pharmaceuticals Limited 2023 2024
Torrent Pharmaceuticals Limited 2022 2023
Torrent Pharmaceuticals Limited 2021 2022
Torrent Pharmaceuticals Limited 2020 2021
Torrent Pharmaceuticals Limited 2019 2020
Torrent Pharmaceuticals Limited 2018 2019
Torrent Pharmaceuticals Limited 2017 2018
Torrent Pharmaceuticals Limited 2016 2017
Torrent Pharmaceuticals Limited 2015 2016
Torrent Pharmaceuticals Limited 2014 2015
Torrent Pharmaceuticals Limited 2013 2014
Torrent Pharmaceuticals Limited 2012 2013
Torrent Pharmaceuticals Limited 2011 2012
Torrent Pharmaceuticals Limited 2010 2011
Torrent Pharmaceuticals Limited 2009 2010

Investor Complaints of Torrent Pharmaceuticals Limited

Event Calendar of Torrent Pharmaceuticals Limited

Company Purpose Details Date
Torrent Pharmaceuticals Limited Bonus/Sub-division To consider, inter-alia, sub-division of the equity shares of the company and issuance of bonus shares to the equity shareholders of the company. 15-Dec-2005
Torrent Pharmaceuticals Limited Financial Results To consider, inter alia, Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on June 30, 2010. 30-Jul-2010
Torrent Pharmaceuticals Limited Results/Others To consider, inter alia, Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company as per Clause 41 of the Listing Agreement for the quarter and half year ended on September 30, 2010. 23-Oct-2010
Torrent Pharmaceuticals Limited Results/Others To consider, inter alia, Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company as per Clause 41 of the Listing Agreement for the quarter and nine months ended on December 31, 2010. 19-Jan-2011
Torrent Pharmaceuticals Limited Results/Dividend To consider, inter alia, the Audited Financial Results of the Company for the year ended on March 31, 2011 and recommendation of dividend for the financial year 2010-11. 28-May-2011
Torrent Pharmaceuticals Limited Financial Results To consider, inter alia, the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis for the quarter ended June 30, 2011. 30-Jul-2011
Torrent Pharmaceuticals Limited Financial Results To consider, inter alia, the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2011. 18-Oct-2011
Torrent Pharmaceuticals Limited Results/Dividend To consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results ( with limited review ) on Consolidated basis of the Company for the quarter ended and nine months ended on December 31, 2011. In the meeting, Board would also consider payment of Interim Dividend for the year 2011-12. 23-Jan-2012
Torrent Pharmaceuticals Limited Results/Dividend To consider, inter alia, the Audited Financial Results for the year ended March 31, 2012 and recommendation of final dividend for the said year. 18-May-2012
Torrent Pharmaceuticals Limited Financial Results Inter alia, to consider & approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the Quarter ended June 30, 2012. 23-Jul-2012
Torrent Pharmaceuticals Limited Financial Results Inter alia, to consider & approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the second quarter and half year ended on September 30, 2012. 26-Oct-2012
Torrent Pharmaceuticals Limited Results/Dividend To consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results ( with limited review ) on Consolidated basis of the Company for the quarter ended and nine months ended on December 31, 2012. In the meeting, Board would also consider payment of Interim Dividend for the year 2012-13. 29-Jan-2013
Torrent Pharmaceuticals Limited Results/Dividend To consider, inter alia, the Audited Financial Results of the Company for the year ended on March 31, 2013 and recommendation of dividend for the said year. 30-May-2013
Torrent Pharmaceuticals Limited Results Inter alia, to consider & approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the Quarter ended June 30, 2013. 26-Jul-2013
Torrent Pharmaceuticals Limited Results Inter alia, to consider & approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2013. 30-Oct-2013
Torrent Pharmaceuticals Limited Results/Dividend The Company had informed the Exchange regarding Board Meeting to be held on January 21, 2014 , inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2013.The company has now informed the Exchange that the Board would also consider payment of Interim Dividend for the year 2013-14. (purpose revised) 21-Jan-2014
Torrent Pharmaceuticals Limited Results inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2013. Further as per the provisions of the Insider Trading Code of the Company, the trading window will remain closed between January 01, 2014 to January 22, 2014. 21-Jan-2014
Torrent Pharmaceuticals Limited Results Inter-alia, to consider and approve the Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on consolidated basis of the Company for quarter and nine months ended December 31, 2013. Further the Company has informed that as per the provisions of the Insider trading code of the Company, the trading window will remain closed between January 01,2014 to January 22, 2014 (Board meeting for, inter-alia, considering above results being held on January 21, 2014.) 21-Jan-2014
Torrent Pharmaceuticals Limited Results To consider ,inter alia, the Audited Financial Results for the year ended on March 31, 2014. Further as per the provisions of the Insider Trading Code of the Company, the trading window will remian closed between April 01, 2014 to May 10, 2014. "The company has provided details of trading window period as per Prohibition of Insider Trading Regulations, 1992 issued by SEBI wherein when the trading window is closed, the employees/directors shall not trade in the company s securities in such period". 09-May-2014
Torrent Pharmaceuticals Limited Results/Dividend The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on May 09, 2014 To consider ,inter alia, the Audited Financial Results for the year ended on March 31, 2014. Further as per the provisions of the Insider Trading Code of the Company, the trading window will remian closed between April 01, 2014 to May 10, 2014."The company has provided details of trading window period as per Prohibition of Insider Trading Regulations, 1992 issued by SEBI wherein when the trading window is closed, the employees/directors shall not trade in the company s securities in such period".The Company has now informed the Exchange that in the above meeting the Board would recommend the Final Dividend for the year ended on March 31, 2014.(purpose revised) 09-May-2014
Torrent Pharmaceuticals Limited Results Inter-alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for quarter ended June 30, 2014. Further the Company has informed that as per the provisions of the Insider Trading Code of the Company, the trading window will remain closed between July 01, 2014 to July 31, 2014 (Board meeting for, inter-alia, considering above results being held on July 30, 2014). 30-Jul-2014
Torrent Pharmaceuticals Limited Results Inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2014. Further, as per the provisions of the Insider Trading Code of the Company, the trading window will remain closed between October 01, 2014 to November 06, 2014 (Board meeting for, inter alia, considering above results being held on November 05, 2014). 05-Nov-2014
Torrent Pharmaceuticals Limited Results inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2014. 28-Jan-2015
Torrent Pharmaceuticals Limited Results/Dividend The Company had Informed Exchange that the meeting of the Board of Directors of the Company to be held on January 28, 2015 for, inter alia, considering and approving the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2014. The Company has now informed Exchange that the Board would also consider payment of lnterim Dividend for the year 2014-15. 28-Jan-2015
Torrent Pharmaceuticals Limited Results inter alia, to consider the Audited Financial Results for the year ended on March 31, 2015. 15-May-2015
Torrent Pharmaceuticals Limited Results Inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on June 30, 2015. 27-Jul-2015
Torrent Pharmaceuticals Limited Results inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2015. 29-Oct-2015
Torrent Pharmaceuticals Limited Results/Dividend Inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited Review) on Consolidated Basis of the Company for the quarter and nine months ended on December 31, 2015. The Board would also consider payment of Interim Dividend for the year 2015-16. 04-Feb-2016
Torrent Pharmaceuticals Limited Dividend To consider inter-alia the proposal for declaration of Second Interim Dividend, if any, for the year 2015-16. 09-Mar-2016
Torrent Pharmaceuticals Limited Issue of Securities To consider inter-alia the proposal for raising of funds by way of: a) Issue of Equity shares including Convertible Bonds/Debentures through Qualified Institutional Placements (QIP) and/ or Depository Receipts and I or any other modes. b) Issue of Unsecured I Secured Redeemable Non-Convertible Debentures/ Bonds by way of Private Placement. 23-Mar-2016
Torrent Pharmaceuticals Limited Results to consider inter-alia the Audited Financial Results for the year ended on March 31, 2016. 23-May-2016
Torrent Pharmaceuticals Limited Results To consider inter-alia the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on June 30, 2016. Further Company would like to inform that, as per the provisions of the Code of Conduct to Regulate, Monitor and Report Trading by Insiders of the Company, the trading window will remain closed between July 13, 2016 to July 29, 2016. 27-Jul-2016
Torrent Pharmaceuticals Limited Results To consider inter-alia the Audited Financial Results on Standalone basis and Unaudited Financial Result (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2016. 26-Oct-2016
Torrent Pharmaceuticals Limited Results/Dividend Inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2016. Further the Board would also consider payment of Interim Dividend for the year 2016-17. 03-Feb-2017
Torrent Pharmaceuticals Limited Results/Dividend Inter alia to consider and approve the Audited Financial Results for the year ended on March 31, 2017 and to consider for recommendation of final dividend for the year ended March 31, 2017. The Board would also consider the proposal for taking the enabling resolutions for raising of funds by way of Issue of Unsecured / Secured Redeemable Non-Convertible Debentures/ Bonds by way of Private Placement. If approved by the Board of Directors, the said item will be placed Shareholders' approval in the ensuing Annual General Meeting. 26-May-2017
Torrent Pharmaceuticals Limited Results inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results ( with limited review) on Consolidated basis of the Company for the quarter ended on June 30, 2017. 31-Jul-2017
Torrent Pharmaceuticals Limited Results inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results ( with Limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2017. 03-Nov-2017
Torrent Pharmaceuticals Limited Raising of Funds to consider inter-alia the following: 1) Issue of Equity shares including Convertible Bonds/Debentures through Qualified Institutional Placement ( QIP) and /or Depository Receipts or any other modes. 2) Issue of Unsecured/Secured Redeemable Non-Convertible Debentures/Bonds by way of private placement. 25-Jan-2018
Torrent Pharmaceuticals Limited Results/Dividend inter alia to consider and approve the Financial Results on Standalone and Consolidated basis of the Company for the quarter and nine months ended on December 31, 2017. 2) In the above meeting, the Board would also consider payment of Interim Dividend for the year 2017-18. 3) As per Regulation 42 of the Listing Regulations, the Company has fixed February 19, 2017,as the Record date for the purpose of payment of said Interim dividend, if declared by the board at their aforesaid meeting, payable to those shareholders whose name appears on the Register of Members or on records of National Securities Depositories Limited or Central Depositories Services ( India) Limited as beneficial owners as on said record date. 08-Feb-2018
Torrent Pharmaceuticals Limited Financial Results/Dividend To consider and approve the financial results for the period ended March 31, 2018 and dividend 30-May-2018
Torrent Pharmaceuticals Limited Financial Results To consider and approve the financial results for the period ended Jun 30, 2018 02-Aug-2018
Torrent Pharmaceuticals Limited Financial Results To consider and approve the financial results for the period ended September 30, 2018 03-Nov-2018
Torrent Pharmaceuticals Limited Financial Results/Dividend/Fund Raising To consider and approve the financial results for the period ended December 31, 2018, dividend and Fund Raising 30-Jan-2019
Torrent Pharmaceuticals Limited Financial Results/Dividend/Fund Raising To consider and approve the financial results for the period ended December 31, 2018, dividend and Fund Raising 30-Jan-2019
Torrent Pharmaceuticals Limited Financial Results/Dividend To consider and approve the financial results for the period ended March 31, 2019 and final dividend 20-May-2019
Torrent Pharmaceuticals Limited Financial Results To consider and approve the financial results for the period ended Jun 30, 2019 23-Jul-2019
Torrent Pharmaceuticals Limited Financial Results To consider and approve the financial results for the period ended September 30, 2019 23-Oct-2019
Torrent Pharmaceuticals Limited Financial Results/Dividend/Fund Raising To consider and approve the financial results for the period ended December 31, 2019, dividend and Fund Raising 27-Jan-2020
Torrent Pharmaceuticals Limited Dividend To consider dividend 11-Mar-2020
Torrent Pharmaceuticals Limited Financial Results To consider and approve the financial results for the period ended March 31, 2020 26-May-2020
Torrent Pharmaceuticals Limited Financial Results To consider and approve the financial results for the period ended Jun 30, 2020 30-Jul-2020
Torrent Pharmaceuticals Limited Financial Results To consider and approve the financial results for the period ended September 30, 2020 26-Oct-2020
Torrent Pharmaceuticals Limited Financial Results/Dividend To consider and approve the financial results for the period ended December 31, 2020 and dividend 08-Feb-2021
Torrent Pharmaceuticals Limited Financial Results/Dividend/Fund Raising To consider and approve the financial results for the period ended March 31, 2021, dividend and Fund Raising 18-May-2021
Torrent Pharmaceuticals Limited Financial Results To consider and approve the financial results for the period ended Jun 30, 2021 27-Jul-2021
Torrent Pharmaceuticals Limited Financial Results To consider and approve the financial results for the period ended September 30, 2021 26-Oct-2021
Torrent Pharmaceuticals Limited Financial Results/Dividend To consider and approve the financial results for the period ended December 31, 2021 and dividend 25-Jan-2022
Torrent Pharmaceuticals Limited Bonus Torrent Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 25-May-2022 to consider Bonus 25-May-2022
Torrent Pharmaceuticals Limited Financial Results/Dividend/Other business matters To consider and approve the financial results for the period ended December 31, 2022, dividend and other business matters 25-Jan-2023
Torrent Pharmaceuticals Limited Financial Results/Dividend/Other business matters To consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters 30-May-2023
Torrent Pharmaceuticals Limited Financial Results To consider and approve the financial results for the period ended September 30, 2023 We would like to inform you that a meeting of the Board of Directors will be held on Monday, 23-Oct-23, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-23. 23-Oct-2023
Torrent Pharmaceuticals Limited Financial Results/Dividend/Other business matters To consider and approve the financial results for the period ended December 31, 2023, dividend and other business matters 02-Feb-2024
Torrent Pharmaceuticals Limited Financial Results/Dividend/Fund Raising To consider and approve the financial results for the period ended March 31, 2024, dividend and Fund Raising 24-May-2024
Torrent Pharmaceuticals Limited Financial Results/Other business matters To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters 23-Jul-2024
Torrent Pharmaceuticals Limited Financial Results/Other business matters To consider and approve the financial results for the period ended September 30, 2024 and other business matters 25-Oct-2024
Torrent Pharmaceuticals Limited Financial Results/Dividend/Other business matters To consider and approve the financial results for the period ended December 31, 2024, dividend and other business matters 24-Jan-2025

Share Transfers of Torrent Pharmaceuticals Limited

Company Period Reg.7 Reg.40 Reg7 Bcast Date Reg40 Bcast Date
Torrent Pharmaceuticals Limited 31-MAR-2024 04-Apr-2024 11:50:04 12-Apr-2024 15:00:05
Torrent Pharmaceuticals Limited 31-MAR-2023 10-Apr-2023 19:10:13 14-Apr-2023 17:00:23
Torrent Pharmaceuticals Limited 31-MAR-2022 12-Apr-2022 19:10:24 12-Apr-2022 18:50:26
Torrent Pharmaceuticals Limited 31-MAR-2021 13-Apr-2021 14:50:09 13-Apr-2021 15:00:09
Torrent Pharmaceuticals Limited 30-SEP-2020 09-Oct-2020 20:20:04 15-Oct-2020 10:50:09
Torrent Pharmaceuticals Limited 31-MAR-2020 06-May-2020 11:00:02 04-May-2020 13:40:01
Torrent Pharmaceuticals Limited 30-SEP-2019 21-Nov-2019 20:30:04 23-Nov-2019 11:10:04
Torrent Pharmaceuticals Limited 31-MAR-2019 10-Apr-2019 11:13:03 20-Nov-2019 18:06:44

Voting Results of Torrent Pharmaceuticals Limited

Date of Mtg. Mtg. Type Resolution R. required Total SHs % favour % against
23-JUL-2024 AGM To receive, consider and adopt the Standalone Financial Statements as at 31st March, 2024 including the Audited Balance Sheet as at 31st March, 2024, the Statement of Profit and Loss for the year ended on that date and reports of the Board of Directors and Auditors thereon. Ordinary 77388 99.97 0.03
23-JUL-2024 AGM Approval for enhancement of limit for the Loan, Guarantee and Investment by the Company under Section 186 of the Companies Act, 2013. Special 77388 88.94 11.06
23-JUL-2024 AGM Remuneration to Non-Executive Directors (NEDs). Ordinary 77388 99.97 0.03
23-JUL-2024 AGM Appointment of Jinal Mehta as Non-Executive Non-Independent Director of the Company. Ordinary 77388 99.92 0.08
23-JUL-2024 AGM Re-appointment of Samir Mehta as Executive Chairman and Fixation of Remuneration. Ordinary 77388 92.67 7.33
23-JUL-2024 AGM Issuance of Equity Shares Including Convertible Bonds / Debentures. Special 77388 100 0
23-JUL-2024 AGM Ratification of Remuneration of Cost Auditors of the Company for the year 2024-25. Ordinary 77388 100 0
23-JUL-2024 AGM Jinesh Shah (holding DIN: 00406498), a director, who retires by rotation at this Annual General Meeting and who has expressed his unwillingness for reappointment, be not re-appointed and the resulting vacancy be not filled up and the number of directors be reduced accordingly. Ordinary 77388 100 0
23-JUL-2024 AGM To confirm the payment of interim dividend of Rs 22.00 per equity share of fully paid up face value of Rs. 5.00 each already paid during the financial year ended 31st March, 2024 and to declare final dividend of Rs. 6.00 per equity share of fully paid up face value of ` 5.00 each for the financial year ended on 31st March, 2024. Ordinary 77388 99.92 0.08
23-JUL-2024 AGM To receive, consider and adopt the Consolidated Financial Statements as at 31st March, 2024 including the Audited Balance Sheet as at 31st March, 2024, the Statement of Profit and Loss for the year ended on that date and reports of the Auditors thereon. Ordinary 77388 99.97 0.03
26-NOV-2023 Postal Ballot Appointment of Shaan Mehta, a relative of Directors as an Executive of the Company Ordinary 74338 88.42 11.58
07-AUG-2023 AGM To receive, consider and adopt the Standalone and Consolidated Financial Statements as at 31st March, 2023 including the Audited Balance Sheet as at 31st March, 2023, the Statement of Profit and Loss for the year ended on that date and reports of the Board of Directors and Auditors thereon. Ordinary 63804 100 0
07-AUG-2023 AGM Appointment of Nikhil Khattau as an Independent Director of the Company. Special 63804 99.96 0.04
07-AUG-2023 AGM Alteration of Articles of Association of the Company. Special 63804 100 0
07-AUG-2023 AGM Issuance of Equity Shares including Convertible Bonds / Debentures. Special 63804 99.54 0.46
07-AUG-2023 AGM Ratification of remuneration of Cost Auditors of the Company for the year 2023-24. Ordinary 63804 100 0
07-AUG-2023 AGM To appoint a Director in place of Samir Mehta (holding DIN 00061903), Director, who retires by rotation, and being eligible, offers himself for re-appointment. Ordinary 63804 96.22 3.78
07-AUG-2023 AGM To confirm the payment of interim dividend of Rs. 14.00 per equity share of fully paid up face value of Rs. 5.00 each already paid during the financial year ended 31st March, 2023 and to declare final dividend of Rs. 8.00 per equity share of fully paid up face value of Rs. 5.00 each for the financial year ended on 31st March, 2023. Ordinary 63804 100 0
08-SEP-2022 Postal Ballot Appointment of Manish Choksi as an Independent Director of the Company Special 69648 99.97 0.03
08-SEP-2022 Postal Ballot Appointment of Aman Mehta as Director and Whole-Time Director of the Company and fixation of remuneration Ordinary 69648 87.9 12.1

FAQs on Torrent Pharmaceuticals Limited

Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.